Article Details

BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment

Retrieved on: 2024-03-15 22:18:40

Tags for this article:

Click the tags to see associated articles and topics

BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment. View article details on hiswai:

Excerpt

Originally operating as a subsidiary under BeiGene, Pi Health has become an independent company with a Series A raise.

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo